Top Page
Innovex International
(NYSE:INVX)
Innovex International (INVX) vs. SPDR S&P 500 ETF (SPY)
Innovex International Business Overview & Revenue Model
Innovex International Earnings Call Summary
Innovex International Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 340.56M | 660.80M | 424.06M | 467.19M | 294.84M | 364.97M |
| Gross Profit | 90.88M | 232.63M | 115.41M | 157.15M | 87.40M | 95.09M |
| EBITDA | -29.26M | 184.77M | 129.93M | 95.43M | 33.59M | -29.04M |
| Net Income | -50.35M | 140.32M | 73.93M | 63.28M | 9.85M | -30.77M |
Balance Sheet | ||||||
| Total Assets | 1.21B | 1.20B | 1.03B | 436.29M | 284.89M | 1.15B |
| Cash, Cash Equivalents and Short-Term Investments | 398.95M | 73.28M | 7.41M | 8.42M | 9.74M | 345.95M |
| Total Debt | 1.54M | 91.07M | 84.91M | 81.40M | 35.24M | 1.25M |
| Total Liabilities | 115.86M | 239.33M | 146.38M | 185.01M | 104.34M | 109.64M |
| Stockholders Equity | 1.09B | 958.16M | 328.92M | 251.28M | 180.55M | 1.04B |
Cash Flow | ||||||
| Free Cash Flow | 12.27M | 79.84M | -24.90M | -15.39M | -8.47M | -33.03M |
| Operating Cash Flow | 21.52M | 93.44M | 75.86M | -5.81M | -2.02M | -21.09M |
| Investing Cash Flow | -123.00K | 78.44M | -79.81M | -37.52M | -22.06M | -5.63M |
| Financing Cash Flow | -131.00K | -103.07M | -124.00K | 42.28M | 10.05M | -25.18M |
Innovex International Technical Analysis
Innovex International Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $1.10B | 6.11 | 13.87% | ― | 72.10% | ― | |
76 Outperform | $1.14B | 14.71 | 7.06% | 3.09% | -9.78% | -49.45% | |
75 Outperform | $1.04B | 15.40 | 4.91% | ― | 10.48% | ― | |
71 Outperform | $980.40M | 11.79 | 5.64% | ― | 0.34% | ― | |
70 Neutral | $1.10B | 26.44 | 4.51% | 3.07% | -4.91% | -46.51% | |
68 Neutral | $15.14B | 9.95 | 6.38% | 5.21% | 4.16% | -67.19% | |
67 Neutral | $1.13B | 41.18 | 8.29% | ― | -9.84% | -111.71% |
Innovex International Corporate Events
On May 30, 2025, Innovex International‘s Board of Directors approved new forms of restricted stock unit (RSU) and performance unit award agreements under its 2025 Long-Term Incentive Plan. These awards, which vest over three years, were granted to key executives and are designed to align their interests with company performance goals, potentially impacting shareholder returns and executive retention.
The most recent analyst rating on (INVX) stock is a Sell with a $13.00 price target. To see the full list of analyst forecasts on Innovex International stock, see the INVX Stock Forecast page.
On May 14, 2025, Innovex International, Inc. held its Annual Meeting of Stockholders where several key proposals were approved. The stockholders approved the 2025 Long-Term Incentive Plan, which allows for the issuance of up to 5,000,000 shares of common stock, and an amendment to the company’s Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 100,000,000 to 200,000,000. Additionally, the election of directors, the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and an advisory vote on executive compensation were also ratified. These decisions are expected to impact the company’s operations by expanding its capacity for stock issuance and strengthening its governance structure.
The most recent analyst rating on (INVX) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Innovex International stock, see the INVX Stock Forecast page.
On May 6, 2025, Innovex International announced its financial results for the first quarter of 2025, reporting a revenue of $240 million, which is a 4% decrease from the previous quarter. The company also highlighted its strategic moves, including the acquisition of SCF Machining Corporation and the planned sale of the Dril-Quip Eldridge facility for $95 million, which is expected to enhance margins and operational performance. Despite lower-than-expected activity in Mexico, Innovex maintained its margins and continued to focus on market opportunities and synergies to support growth. The company also initiated a $100 million share repurchase program and reported a net cash balance of $43 million at the end of the quarter.
On April 21, 2025, Innovex International announced a definitive agreement to sell its Eldridge facility in Houston, Texas, to BIG Acquisitions LLC for $95 million, with the sale expected to close in the third quarter of 2025. This transaction is part of Innovex’s strategy to transform its business, with CEO Adam Anderson highlighting the sale as a significant milestone that will reduce the company’s operating footprint in Houston by 82%, improve delivery and responsiveness, and strengthen its balance sheet. The proceeds will support a $100 million share buyback and potential M&A activities. Despite a decline in Q1 2025 revenue, Innovex anticipates adjusted EBITDA between $44-$46 million, demonstrating resilience in uncertain market conditions.